Bulbitech will be exhibiting at UKNOS 2025
Join Us at UKNOS 2025! We’re excited to announce that Bulbitech will be exhibiting at UKNOS 2025 in London on February 27th! Our CCO, Dennis Hens, and Chief Medical […]
Join Us at UKNOS 2025! We’re excited to announce that Bulbitech will be exhibiting at UKNOS 2025 in London on February 27th! Our CCO, Dennis Hens, and Chief Medical […]
As previously announced, Institut Català de Retina (ICR) took part in a pilot study that utilizes BulbiCAM as a tool for early […]
Bulbitech is attending the FLORetina-ICOOR Meeting 2024 (Floretina ICOOR 2024) from December 5th to 8th at the Firenze Fiera convention center in […]
Exciting news for anyone passionate about advancing ophthalmology! Join Bulbitech at the NHS Research Scotland Ophthalmology and Scottish Eye Research and Innovation […]
Innovative Research on Thyroid Eye Disease In a notable achievement at the Innovate Thyroid Eye Disease (TED) 2024 Multidisciplinary Symposium, Dr. Jimmy […]
Bulbitech and Meddoc Medical Research Institute, Norway, in collaboration with the Neurological Department at Oslo University Hospital, will soon release promising results […]
Bulbitech revolutionises eye and neurological disease diagnostics and care. Bulbitech delivers AI-powered eye-tracking technology that screens for ophthalmological and neurological disorders. “Our […]
We’re proud to announce we’ve been shortlisted as one of the 15 companies of the Digital Health’s Rewired 2024 Pitchfest Heaths. Looking […]
Bulbitech has raised 5,7 MNOK in an emission and 4,8 MNOK in convertible loans as part of a bridge round with existing […]
Bulbitech is delighted to inform you that we are welcoming Richard John Connors to our team as part of the MSCA Doctoral […]